23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI.

Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider has learned.

Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...

The struggling health company bought the virtual-care startup Lemonaid in 2021 for $400 million. 23andMe's stock plummeted after a 2023 data breach exposed millions of customer accounts.

Me (ME) forms special board committee to explore strategic alternatives, including sale, restructuring, or business ...

Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to Business Insider. The company, which has faced financial difficulties, ...

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Cost: If the price for branded Viagra pills is outside your budget, Lemonaid’s $2 sildenafil pills are some of the lowest priced Viagra alternatives we’ve found. Lemonaid is a telemedicine ...

All of the medications available for ED are generic: No brand-name drugs are available. To use Lemonaid, you start by filling out an online assessment with information on your health history and ...